The Guide to IMMUNOPHARMACOLOGY (GtoImmuPdb) is a Wellcome Trust-funded extension to the existing Guide to PHARMACOLOGY (GtoPdb). The development of GtoImmuPdb aims to provide improved data exchange between immunology and pharmacology expert communities, so to better support research and development of drugs targeted at modulating immune, inflammatory or infectious components of disease.

The underlying GtoPdb schema has been extended to incorporate new immune system specific data types and the GtoPdb website has been developed to surface this new data and incorporate it into the existing search and browse mechanisms. A new Guide to IMMUNOPHARMACOLOGY portal has been developed, which serves as a unique immunological access-point to the Guide to PHARMACOLOGY.

Click here to access the database

For more information on the parent Guide to PHARMACOLOGY see the About page and the FAQ.

Cardiovascular Research OnLife Interview

In this Onlife interview, Dr. Pasquale Maffia (University of Glasgow) interviews Prof. Alberto Mantovani (IUIS President) and Prof. Michael Spedding (IUPHAR Secretary General) on the IUPHAR Guide to Immunopharmacology, its relevance to cardiovascular research community and more.

Read the full Cardiovascular Research article

Contact us

If you would like to get in touch with any comments, questions, error reports and suggestions please email us.

How to cite

Please refer to this page for details on how to cite the information contained in the Guide to PHARMACOLOGY and the Guide to IMMUNOPHARMACOLOGY


Scientific Advisors for IUPHAR Guide to Immunopharmacology

Stephen P.H. Alexander, UK
Stephen Anderton, UK
Clare Bryant, UK
Anthony P. Davenport, UK
Jamie A. Davies, UK
Christian Doerig, Australia
Doriano Fabbro, Switzerland
Francesca Levi-Schaffer, Israel
Michael Spedding, France

Database Development and Curation

Dr. Simon D. Harding, Senior Database Developer, UK
Dr. Elena Faccenda, Database Curator, UK
Dr. Christopher Southan, Database Curator, UK

We'd also like to acknowledge contributions from the IUPHAR ImmuPhar Section and to Dr. Pasquale Maffia, Institute of Infection, Immunity & Inflammation, University of Glasgow.


Founded in 1959 as a section of the International Union of Physiological Sciences, the International Union of Basic and Clinical Pharmacology (IUPHAR) has been independent since 1966. IUPHAR is a member of the International Council for Science (ICSU) and participates in the work of its scientific committees. It receives international recognition, particularly by the United Nations Educational, Scientific and Cultural Organization (UNESCO).

The IUPHAR Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR, links to GtoPdb site), founded in 1987, is chaired by Michael Spedding (France) and has the mission of issuing guidelines for receptor and ion channel classification, addressing the main issues in pharmacology today, classifying the major receptor and ion channel systems, facilitating the interface between the discovery of new sequences from the Human Genome Project and the designation of the derived proteins as functional receptors and ion channels and maintaining a website (the IUPHAR/BPS Guide to PHARMACOLOGY portal) with access to data on all known receptor systems, freely available to all scientists, anywhere in the world. NC-IUPHAR publishes articles on receptor nomenclature and guidelines for terminology in Pharmacological Reviews, in collaboration with ASPET, and also publishes reviews and editorials on other topics in the British Journal of Pharmacology.

Click here for the full publication list. (links to GtoPdb site)